Dokumente im Korb
Helmholtz Zentrum München
|
Imprint
PuSH - Publication Server of Helmholtz Zentrum München
Navigation
Home
Deutsch
Research
Advanced Search
Browse by ...
... Journal
... Publication Type
... Research Data
... Publication Year
Publication overview
Support & Contact
Contact persons
Help
Data protection
Doll, S.
;
Proneth, B.
; Tyurina, A.A.* ;
Panzilius, E.
;
Kobayashi, S.
;
Ingold, I.
;
Irmler, M.
;
Beckers, J.
;
Aichler, M.
;
Walch, A.K.
;
Prokisch, H.
;
Trümbach, D.
; Mao, G.* ; Qu, F.* ; Bayir, H.* ; Füllekrug, J.* ;
Scheel, C.
;
Wurst, W.
;
Schick, J.
; Kagan, V.E.* ;
Friedmann Angeli, J.P.F.
;
Conrad, M.
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
Nat. Chem. Biol.
13
, 91-98 (2017)
Postprint
Research data
DOI
PMC
Open Access Green
as soon as is submitted to ZB.
Abstract
Metrics
Extra information
© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches—a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines—to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4–Acsl4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated ω6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.
Altmetric
Additional Metrics?
[➜Log in]
Tags
Annotations
Special Publikation
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Placebo-controlled Trial; Glutathione-peroxidase 4; Focal Cerebral-ischemia; Coa Synthetase 4; Nonalcoholic Steatohepatitis; Therapeutic Target; Death; Pioglitazone; Cancer; Cells
Keywords plus
ISSN (print) / ISBN
1552-4450
e-ISSN
1552-4469
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Journal
Nature Chemical Biology
Quellenangaben
Volume: 13,
Issue: 1,
Pages: 91-98
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
Basingstoke
University
University place
Faculty
Publication date
0000-00-00
Application number
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Developmental Genetics (IDG)
Institute of Experimental Genetics (IEG)
Institute of Stem Cell Research (ISF)
Research Unit Analytical Pathology (AAP)
Institute of Human Genetics (IHG)
Institute of Molecular Toxicology and Pharmacology (TOXI)
Grants